《大行報告》瑞銀上調人保(01339.HK)目標價至3.5元 評級「買入」
瑞銀發表報告,指人保集團(01339.HK)首季純利按年升42.1%至100.34億元人民幣,財險綜合成本率95.7%,按年下跌1.4個百分點,表現好過預期。至於汽車保險綜合成本為94.6%,明顯好於市場預期。而壽險首年保費下降18%,亦都符合預期,因啟動和醫療保險的競爭。
瑞銀將人保2021至2023年稅後純利預測提高7%至11%,以反映人保在財險方面更好的費用控制及在車險綜合改革後的成本控制能力,將目標價格從3.3元提高到3.5元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.